Enteropathogens and chronic illness in returning travelers

New England Journal of Medicine

Volumn 368, Issue 19, 2013, Pages 1817-1825

  Ross, Allen G P ^a   Olds, G Richard ^c   Cripps, Allan W ^a   Farrar, Jeremy J ^d   McManus, Donald P ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; AURANOFIN; AZITHROMYCIN; BISMUTH SALICYLATE; CIPROFLOXACIN; DIPHENOXYLATE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENTAMOEBA HISTOLYTICA EH29 CT B FUSION PROTEIN ORAL VACCINE; GIARDIA LAMBLIA ALPHA1 GIARDIN BASED LIVE HETEROLOGOUS VACCINE; GLUCOCORTICOID; INFUSION FLUID; IVERMECTIN; LOPERAMIDE; METRONIDAZOLE; NITAZOXANIDE; ORAL REHYDRATION SOLUTION; PARASITE ANTIBODY; PARASITE ANTIGEN; PAROMOMYCIN; PRAZIQUANTEL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RINGER LACTATE SOLUTION; SHIGELLA FLEXNERI 2A CONJUGATE VACCINE; SHIGELLA SONNEI VIRG LIVE ATTENUATED VACCINE; TY21A VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VI CONJUGATE SALMONELLA ENTERICA TYPHI VACCINE; ZINC;

ABDOMINAL PAIN; AEROMONAS; AMEBIASIS; ANTIBIOTIC RESISTANCE; ANTIBODY DETECTION; BACTEREMIA; BLOOD CELL COUNT; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CHRONIC DISEASE; CRYPTOSPORIDIUM; CYCLOSPORA; DEATH; DEHYDRATION; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MEGADOSE; DRUG POTENCY; DUODENUM BIOPSY; ELECTROLYTE DISTURBANCE; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; GIARDIA LAMBLIA; GIARDIASIS; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS DIARRHEA; INTERMETHOD COMPARISON; INTESTINE INFECTION; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; ISOSPORA; MEDICAL HISTORY; MICROARRAY ANALYSIS; MICROBIAL IDENTIFICATION; MICROSPORIDIA; MULTIDRUG RESISTANCE; NAUSEA; NONHUMAN; PERITONITIS; PHYSICAL EXAMINATION; PLESIOMONAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; ROTAVIRUS; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SELF MEDICATION; SENSITIVITY AND SPECIFICITY; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TOXIC MEGACOLON; TRAVEL; TRAVELLER DIARRHEA; TROPICAL DISEASE; TYPHOID FEVER; WEIGHT REDUCTION;

EID: 84877620487     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1207777     Document Type: Article

References (67)

1. United Nations. UNWTO tourism highlights. 2012 edition (http://dtxtq4w60xqpw.cloudfront.net/sites/all/files/docpdf/ unwtohighlights12enlr-1.pdf).
2. Cartwright R. Gastrointestinal illness in tourists: whose responsibility? Euro Surveill 2004;9(3):5.
3. Gorbach SL. How to hit the runs for fifty million travelers at risk. Ann Intern Med 2005;142:861-2.
4. Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute and persistent diarrhea. Gastroenterology 2009;136:1874-86.
5. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006;354:119-30. [Erratum, N Engl J Med 2006;355:967.]
6. Navaneethan U, Giannella RA. Infectious colitis. Curr Opin Gastroenterol 2011;27:66-71.
7. DuPont HL. Bacterial diarrhea. N Engl J Med 2009;361:1560-9.
8. Hill DR. The burden of illness in international travelers. N Engl J Med 2006;354:115-7.
9. Swaminathan A, Torresi J, Schlagenhauf P, et al. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. J Infect 2009;59:19-27.
10. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009;80:609-14.
11. Thielman NM, Guerrant RL. Acute infectious diarrhea. N Engl J Med 2004;350:38-47.
12. DuPont HL. What's new in enteric infectious diseases at home and abroad? Curr Opin Infect Dis 2005;18:407-12.
13. Ansart S, Perez L, Vergelt O, Danis M. Illness in travelers returning from the tropics: a prospective study of 622 patients. J Travel Med 2005;12:312-8.
14. Nicolls DJ, Weld LH, Schwartz E, et al. Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008. Am J Trop Med Hyg 2008;79:729-34.
15. Marano C, Freedman DO. Global health surveillance and travelers' health. Curr Opin Infect Dis 2009;22:423-9.
16. Andersen MD, Neumann NF. Giardia intestinalis: new insights on an old pathogen. Med Microbiol 2007;18:35-42.
17. Carranza PG, Lujan HD. New insights regarding the biology of Giardia lamblia. Microbes Infect 2010;12:71-80.
18. Jerlström-Hulqvist J, Ankarklev J, Svärd SG. Is human giardiasis caused by two different Giardia species? Gut Microbes 2010;1:379-82.
19. Bhavnani D, Goldstick JE, Cevallos W, Trueba G, Eisenberg JNS. Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: evidence from a community-based study in Northeastern Ecuador. Am J Epidemiol 2012;176:387-95.
20. Ankarklev J, Jerlström-Hulqvist J, Ringqvist E, Troell K, Svärd SG. Behind the smile: cell biology and disease mechanism of Giardia species. Nat Rev Microbiol 2010;8:413-22.
21. Cotton JA, Beatty JK, Buret AG. Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol 2011;41:925-33.
22. Buret AG, Mitchell K, Muench DG, Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in nontransformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 2002;125:11-9.
23. Scott KG, Yu LC, Buret AG. Role of CD8+ and CD4+ T lymphocytes in jejunal mucosal injury during murine giardiasis. Infect Immun 2004;72:3536-42.
24. Solaymani-Mohammadi S, Singer SM. Giardia duodenalis: the double-edge sword of immune responses to giardiasis. Exp Parasitol 2010;126:292-7.
25. Mortimer L, Chadee K. The immunopathogenesis of Entamoeba histolytica. Exp Parasitol 2010;126:366-80.
26. Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc 2008;83:1154-9.
27. Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who have sex with men. Lancet Infect Dis 2012;12:729-36.
28. Mukherjee S, Nagarsenkar A, Chandra S, Sahasrabhojanee M, Sawant D. Ameobic cervicitis mimicking posterior wall fibroid: a rare presentation. J Micro Immunol Infect 2012 June 26 (Epub ahead of print).
29. Olsen A, van Lieshout L, Marti H, et al. Strongyloidiasis - the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 2009;103:967-72.
30. Segarra-Newnham M. Manifestations, diagnosis and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007;41:1992-2001.
31. Iriemenam NC, Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF. Strongyloides stercoralis and the immune response. Parasitol Int 2010;59:9-14.
32. Casburn-Jones AC, Farthing MJG. Management of infectious diarrhoea. Gut 2004;53:296-305.
33. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006;368:1106-18.
34. Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. BMJ 2011;342:d2651.
35. Ross AGP, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis 2007;7:218-24.
36. Schlenker C, Surawicz CM. Emerging infections of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2009;23:89-99.
37. Kirkpatrick BD, Tribble DR. Update on human Campylobacter jejuni infections. Curr Opin Gastroenterol 2011;27:1-7.
38. van Putten JP, van Alphen LB, Wosten MM, de Zoete MR. Molecular mechanisms of Campylobacter infection. Curr Top Microbiol Immunol 2009;337:197-229.
39. Hu L, Tall BD, Curtis SK, Kopecko DJ. Enhanced microscopic definition of Campylobacter jejuni 81-176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells. Infect Immun 2008;76:5294-304.
40. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 2010;300:205-11.
41. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011;8:669-85.
42. Gordon MA. Invasive non-typhoidal Salmonella disease - epidemiology, pathogenesis, and diagnosis. Curr Opin Infect Dis 2011;24:484-9.
43. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012;379:2489-99.
44. DuPont HL. Approach to the patient with infectious colitis. Curr Opin Gastroenterol 2012;28:39-46.
45. Jess T, Simonsen J, Nielsen NM, et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 2011;60:318-24.
46. Hapfelmeier S, Stecher B, Barthel M, et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88odependent and MyD88-independent mechanisms. J Immunol 2005;174:1675-85.
47. Dougan G, John V, Palmer S, Mastroeni P. Immunity to salmonellosis. Immunol Rev 2011;240:196-210.
48. Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: an update on epidemiology, management, and prevention. Travel Med Infect Dis 2011;9:263-77.
49. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med 2004;351:2417-27.
50. Phalipon A, Sansonetti PJ. Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development. Crit Rev Immunol 2003;23:371-401.
51. Singh A, Houpt E, Petri WA. Rapid diagnosis of intestinal parasitic protozoa with a focus on Entamoeba histolytica. Interdiscip Perspect Infect Dis 2009;2009:547090.
52. Parr JB, Sevilleja JE, Amidou S, et al. Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction. Am J Trop Med Hyg 2007;76:938-42.
53. ten Hove R, Schuurman T, Kooistra M, Møller L, van Lieshout L, Verweij JJ. Detection of diarrhoea-causing protozoa in general practise patients in the Netherlands by multiplex real-time PCR. Clin Microbiol Infect 2007;13:1001-7.
54. Marotta F, Zilli K, Tonelli A, Sacchini L, et al. Detection and genotyping of Campylobacter jejuni by use of DNA oligonucleotide arrays. Mol Biotechnol 2013;53:182-8.
55. Han J, Wang Y, Sahin O, Shen Z, Guo B, Shen J. Zhang Q. A fluoroquinolone resistance associated mutation in gyrA affects DNA supercoiling in Campylobacter jejuni. Front Cell Infect Microbio 20122:21.
56. Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 2012;25:458-63.
57. Adachi JA, DuPont HL. Rifaxmin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis 2006;42:541-7.
58. Rossignol JF, Lopez-Chegne N, Julcamoro LM, Carrion ME, Bardin MC. Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg 2012;106:167-73.
59. Debnath A, Parsonage D, Andrade RM, et al. A high-throughput drug screen for Entamoeba histolytica indentifies a new lead and target. Nat Med 2012;18:956-60.
60. Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev 2011;239:125-48.
61. Jenikova G, Hruz P, Andersson MK, et al. α1-Giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model. Vaccine 2011;29:9529-37.
62. Carrero JC, Contreras-Rojas A, Sánchez-Hernández B, et al. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin. Exp Parasitol 2010;126:359-65.
63. Kweon MN. Shigellosis: the current status of vaccine development. Curr Opin Infect Dis 2008;21:313-8.
64. Kosek M, Yori PP, Olortegui MP. Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas. Curr Opin Infect Dis 2010;23:475-80.
65. Tran MH, Pearson MS, Bethony JM, et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006;12:835-40.
66. Da'dara AA, Li YS, Xiong T, et al. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008;26:3617-25.
67. Ramana J, Tamanna. dbDiarrhea: the database of pathogen proteins and vaccine antigens from diarrheal pathogens. Infect Genet Evol 2012;12:1647-51.